Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN
NCT06474078
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Stevens-Johnson Syndrome
Toxic Epidermal Necrolysis
Interventions
DRUG:
Tofacitinib
Sponsor
Chang Gung Memorial Hospital